BRK-B vs HBNC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HBNC presents a stark contradiction between valuation and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock appears undervalued with a Forward P/E of 8.07 and a PEG of 0.80, the negative ROE (-20.73%) and ROA (-2.11%) indicate significant operational inefficiency or temporary distress. Despite astronomical revenue growth (218.7%), earnings are declining YoY (-18.5%), suggesting that top-line expansion is not translating to profitability. The technical trend is currently bearish (0/100), offsetting the positive analyst target of $20.80.
Compare Another Pair
Related Comparisons
BRK-B vs HBNC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Horizon Bancorp, Inc. (HBNC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.